PharmaLegacy Laboratories (Shanghai) Co., Ltd was founded in 10 years ago, After a period of rapid development, it has developed into a considerable size and effectiveness company of Respiratory Disease ModelandNon-Human Primates modelsx2a38631n, NOw it is benchmark companies in 商务服务,医疗服务,医疗保健 industry.
Innovation is the cornerstones of PharmaLegacy Laboratories (Shanghai) Co., Ltds success. In the future, PharmaLegacy also hope to continue to innovate, for the majority of customers to provide Humanized miceservice. Over the years, PharmaLegacy always believe that only adhere to innovation and professional, in order to better meet customer demand for Syngeneic mouse model good word of mouth. details:Immunotherapeutics fight cancer by taking advantage of a patient's own immune system, therefore, preclinical research into new therapies requires appropriate models with fully functional immunity. Syngeneic mouse model (allografts derived from immortalized mouse cancer cell lines which originated from the same inbred strain of mice) provide a valuable system for assessing new single agent, combination immunotherapies, or combination radiotherapy within mice with fully competent immunity. Pharmalegacy provides a panel of well validated syngeneic mouse models for preclinical immunotherapy research, used to interrogating novel immune-oncology treatments via activating the mouse immune system. We have model types include subcutaneous, orthotopic and metastatic. Our suite of syngeneic mouse model includes 22 models covering 14 cancer types and more on going, which validated with anti-PD-1, PD-L1 and anti-CTLA-4 antibodies
Adhering to the "Customer Supreme Forge Ahead" management idea, PharmaLegacy insists on providing the best quality and service of Humanized mice,Syngeneic mouse model with the "customer first" principle. Wholeheartedly welcome your patronage! Official website address: www.pharmalegacy.com
bio-equip.cn
中文
